Clarification sought from Lupin
Date: 29-03-2016The Exchange has sought clarification from Lupin with reference to the news flashed on CNBC TV 18 ‘Mandideep unit inspected by US FDA from 8-19 Feb 2016. US FDA observations at Mandideep unit are serious in nature and the unit gets 483 letter’.
The above information is a part of company’s filings submitted to BSE.